Gastos De Venta Y Administración Cambio Fecha
AbbVie USD 3.84B 205M 2026-09
Alaunos Therapeutics USD 424K 23K 2026-06
AstraZeneca USD 4.07B 1.73B 2026-09
Curis USD 2.96M 1.62M 2026-03
Cytokinetics USD 113.14M 8.75M 2026-09
Gilead Sciences USD 1.52B 70M 2026-06
Incyte USD 364.27M 12.54M 2026-09
Laboratory Of America USD 611.4M 34.2M 2026-09
Novartis USD 3.08B 163M 2026-09
Pfizer USD 3.28B 132M 2026-09
Roche Holding CHF 6.37B 908M 2026-06
TG Therapeutics USD 62.32M 10.82M 2026-06
Verastem USD 22.3M 2.14M 2026-03